Contrarius Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $42.1M | Buy |
2,047,218
+131,808
| +7% | +$2.71M | 2.39% | 15 |
|
|
2024
Q2 | $42.9M | Buy |
1,915,410
+564,879
| +42% | +$12.6M | 2.68% | 16 |
|
|
2024
Q1 | $37.2M | Buy |
1,350,531
+1,136,130
| +530% | +$31.3M | 2.15% | 17 |
|
|
2023
Q4 | $6.54M | Sell |
214,401
-17,461
| -8% | -$532K | 0.35% | 37 |
|
|
2023
Q3 | $7.33M | Sell |
231,862
-62,177
| -21% | -$1.97M | 0.41% | 37 |
|
|
2023
Q2 | $12M | Buy |
+294,039
| New | +$12M | 0.65% | 33 |
|